Registration Strip Icon for tools Aumente o nível de sua negociação com nossas ferramentas poderosas e insights em tempo real, tudo em um só lugar.

LADX

LadRx (QB) (LADX)

LadRx Corporation (QB)
De:
Ordenação:
 Apresentando as notícias mais relevantes sobre:USOTC:LADX
DataHoraFonteTítuloCódigoCompanhia
14/11/202408:27Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]USOTC:LADXLadRx Corporation (QB)
09/10/202407:04Edgar (US Regulatory)Form 8-K - Current reportUSOTC:LADXLadRx Corporation (QB)
20/08/202407:05Edgar (US Regulatory)Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) materialUSOTC:LADXLadRx Corporation (QB)
20/08/202407:03Edgar (US Regulatory)Form DEF 14A - Other definitive proxy statementsUSOTC:LADXLadRx Corporation (QB)
14/02/202416:49Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]USOTC:LADXLadRx Corporation (QB)
29/01/202418:06Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesUSOTC:LADXLadRx Corporation (QB)
11/01/202418:50Dow Jones NewsXoma to Make $1 Million Milestone Payment to LadRx After FDA Accepts Zevra Application for ArimoclomolUSOTC:LADXLadRx Corporation (QB)
12/10/202307:08Edgar (US Regulatory)Form 8-K/A - Current report: [Amend]USOTC:LADXLadRx Corporation (QB)
 Apresentando as notícias mais relevantes sobre:USOTC:LADX